In vitro activity of a novel des-fluoro(6) quinolone, garenoxacin (BMS-284756), against rapidly growing mycobacteria and Nocardia isolates.

作者信息

Valera Lourdes, Gradelski Elizabeth, Huczko Elizabeth, Washo Thomas, Yigit Hesna, Fung-Tomc Joan

出版信息

J Antimicrob Chemother. 2002 Jul;50(1):140-2. doi: 10.1093/jac/dkf081.

DOI:10.1093/jac/dkf081

PMID:12096023

Abstract

摘要

相似文献

In vitro activity of a novel des-fluoro(6) quinolone, garenoxacin (BMS-284756), against rapidly growing mycobacteria and Nocardia isolates.

J Antimicrob Chemother. 2002 Jul;50(1):140-2. doi: 10.1093/jac/dkf081.

The in vitro activity of BMS-284756, a new des-fluorinated quinolone.

J Antimicrob Chemother. 2002 Jan;49(1):177-84. doi: 10.1093/jac/49.1.177.

Susceptibility of rapidly growing mycobacteria and Nocardia isolates from cats and dogs to pradofloxacin.

Vet Microbiol. 2011 Dec 15;153(3-4):240-5. doi: 10.1016/j.vetmic.2011.06.001. Epub 2011 Jun 15.

Increased in vitro activity of the novel des-fluoro(6) quinolone BMS-284756 against genetically defined clinical isolates of Staphylococcus aureus.

J Antimicrob Chemother. 2002 Feb;49(2):283-7. doi: 10.1093/jac/49.2.283.

Comparative in-vitro activity of sparfloxacin and eight other antimicrobial agents against clinical isolates of non-tuberculous mycobacteria.

J Antimicrob Chemother. 1996 Jan;37(1):151-4. doi: 10.1093/jac/37.1.151.

In vitro activities of garenoxacin (BMS-284756) against 170 clinical isolates of nine Pasteurella species.

Antimicrob Agents Chemother. 2002 Sep;46(9):3068-70. doi: 10.1128/AAC.46.9.3068-3070.2002.

In Vitro Comparison of Ertapenem, Meropenem, and Imipenem against Isolates of Rapidly Growing Mycobacteria and Nocardia by Use of Broth Microdilution and Etest.

J Clin Microbiol. 2016 Jun;54(6):1586-1592. doi: 10.1128/JCM.00298-16. Epub 2016 Apr 6.

Comparative in vitro activity of garenoxacin against Chlamydia spp.

J Antimicrob Chemother. 2002 Sep;50(3):407-10. doi: 10.1093/jac/dkf145.

In vitro activity of the novel des-F(6) quinolone BMS-284756 against genetically characterized clinical streptococcal isolates, including isolates with reduced quinolone susceptibility.

J Antimicrob Chemother. 2002 Apr;49(4):698-701. doi: 10.1093/jac/49.4.698.

Antimicrobial activity of BMS 284756, a novel des-fluoro (6) quinolone and seven fluoroquinolones against Streptococcus pneumoniae.

Clin Microbiol Infect. 2001 Oct;7(10):572-3.

引用本文的文献

In vitro activities of new quinolones and oxazolidinones against Actinomadura madurae.

Antimicrob Agents Chemother. 2004 Mar;48(3):1037-9. doi: 10.1128/AAC.48.3.1037-1039.2004.

In vitro and in vivo activities of antimicrobials against Nocardia brasiliensis.

Antimicrob Agents Chemother. 2004 Mar;48(3):832-7. doi: 10.1128/AAC.48.3.832-837.2004.

In vitro activities of new antimicrobials against Nocardia brasiliensis.

Antimicrob Agents Chemother. 2004 Feb;48(2):602-4. doi: 10.1128/AAC.48.2.602-604.2004.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验